Kailera Therapeutics, Inc. (KLRA)

Kailera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Apr 21, 2026	Dec 31, 2025	Dec 31, 2024
Market Capitalization	3,030	-	-
Enterprise Value	2,402	-	-
Debt / Equity Ratio	0.02	0.02	0.00
Net Debt / Equity Ratio	-1.01	-1.01	-1.02
Net Debt / EBITDA Ratio	4.06	4.06	7.15
Net Debt / FCF Ratio	5.25	5.25	0.94
Quick Ratio	11.83	11.83	25.35
Current Ratio	12.02	12.02	25.70
Return on Equity (ROE)	-36.90%	-36.90%	-
Return on Assets (ROA)	-22.73%	-22.73%	-
Return on Capital Employed (ROCE)	-24.50%	-24.50%	-14.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q